drugset / Trial / NCT02458157

Forced Fluid Removal in High Risk Acute Kidney Injury

NCT02458157

RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this pilot trial is to assess the feasibility of forced fluid removal in patients admitted to the intensive care unit (ICU) with high-risk AKI and severe fluid overload. The intervention will use furosemide infusion and/or continuous renal replacement therapy (CRRT) to achieve and maintain a neutral cumulative fluid balance. The intervention will be compared to standard of care as reflected in the kidney disease improving global outcome (KDIGO) guidelines.

Timeline

Start
2015-10
Primary completion
2017-06-08
Completion
2017-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 40 mg Intravenous

Indications